MedPath

Effectiveness of smartphone-based mobile application on medication adherence in patients receiving growth hormone therapy-An exploratory observational study. (GTL-App)

Not Applicable
Conditions
Short statue caused by -Growth hormone (GH) deficiency -Turner syndrome -Small for gestational age
Registration Number
JPRN-UMIN000035997
Lead Sponsor
Department of Pediatrics, Nihon University Hospital
Brief Summary

This study enrolled 60 children with short stature from 28 Japanese medical institutions and analyzed 57 of them. The median and mean adherence rates after 24 wk of observation were 96% and 93%, respectively. Although adherence rates were significantly lower from wk 16 to wk 20 than from wk 1 to wk 4, cumulative adherence rates remained high throughout the observation period. The questionnaire analysis revealed that most patients actively used the application.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

-Contraindications for GH therapy. eg, Diabetes, malignancy, (possible) pregnancy. -Not supposed to be able to answer the questionnaire properly, eg, unable to read. -Judgement of physicians.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medication adherence of patients during 24 weeks of observation period.
Secondary Outcome Measures
NameTimeMethod
-Patients characteristics at registration. -Time course change in medication adherence. -Nonadherence-free survival. -Questionnaire on GH therapy. -Questionnaire on mobile application. -Factors affecting adherence to GH therapy. -Exploratory analysis of application log data.
© Copyright 2025. All Rights Reserved by MedPath